Publikationen, an denen er mitarbeitet Francisco Javier Rodríguez Berrocal (10)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2014

  1. Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease

    Scientific Reports, Vol. 4

  2. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

    PLoS ONE, Vol. 9, Núm. 9

2010

  1. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas

    BMC Cancer, Vol. 10

2009

  1. Soluble CD26 levels and its association to epidemiologic parameters in a sample population

    Disease Markers, Vol. 27, Núm. 6, pp. 311-316

2008

  1. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer

    Anticancer Research, Vol. 28, Núm. 4 C, pp. 2333-2341

2007

  1. Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma

    British Journal of Cancer, Vol. 96, Núm. 10, pp. 1569-1578

2003

  1. Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer

    Disease Markers, Vol. 19, Núm. 6, pp. 267-272

2001

  1. Cell surface human α-L-fucosidase

    European Journal of Biochemistry, Vol. 268, Núm. 11, pp. 3321-3331

2000

  1. Preoperative serum CD26 levels: Diagnostic efficiency and predictive value for colorectal cancer

    British Journal of Cancer, Vol. 83, Núm. 9, pp. 1139-1146